Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
InnoGenomics is a private biotechnology and diagnostics company focused on genetic testing solutions spanning forensic DNA analysis and selected molecular diagnostic applications. The company commercializes products for challenging forensic samples, including sperm differential extraction, DNA quantification, DNA typing, and extraction workflows for rootless hair shafts, touch DNA, and degraded bone. Its core technology is based on patented genomic marker and sample-processing approaches supported by National Science Foundation SBIR funding. In addition to products, InnoGenomics offers custom laboratory services, validations, mock forensic samples, and training for forensic laboratories. The company has also described development of a liquid biopsy approach for cancer detection and treatment monitoring, but its visible commercial footprint appears centered on forensic genomics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on InnoGenomics Technologies.